| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to the prescription of a controlled substance for certain |
|
|
patients and continued treatment of those patients. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Subchapter C, Chapter 481, Health and Safety |
|
|
Code, is amended by adding Section 481.0725 to read as follows: |
|
|
Sec. 481.0725. PRESCRIPTION OF CONTROLLED SUBSTANCE AND |
|
|
CONTINUED TREATMENT OF PATIENT AFTER DRUG TEST. A practitioner may |
|
|
not refuse to prescribe a controlled substance for the treatment of |
|
|
pain to a patient or refuse to continue treating the patient solely |
|
|
because the results of a drug test taken by the patient indicated |
|
|
that tetrahydrocannabinol or cannabidiol was present in the |
|
|
patient's body. |
|
|
SECTION 2. The change in law made by this Act applies only |
|
|
to a prescription issued on or after the effective date of this Act. |
|
|
A prescription issued before the effective date of this Act is |
|
|
governed by the law in effect on the date the prescription is |
|
|
issued, and the former law is continued in effect for that purpose. |
|
|
SECTION 3. This Act takes effect September 1, 2023. |